This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Helene Finney, PhD
Director, Functional Screening at UCB


Helene joined UCB (then Celltech) in 1989 and has gained
expertise in a range of antibody technologies. Her PhD studies
at UCB in gene therapy generated the first co-stimulation
signal inclusive (now termed “second generation”) CAR-T
cell constructs. She has led a variety of antibody technology
teams & early stage therapeutic antibody discovery projects
for oncology, bone, immunology/inflammation & CNS
targets. Helene now leads the UCB Functional Screening
project team; combining cutting edge antibody & screening
technology to discover break-through bispecific antibody
drugs across multiple therapeutic areas.

Agenda Sessions

  • Accessing Novel Functionalities of Bispecific Antibodies - Target Pair Discovery by Screening a Large "Select, Mix and Assay" Combinatorial Library